Disease-modifying therapy prescription patterns in people with multiple sclerosis by age.

Zhang, Yinan; Salter, Amber; Jin, Shan; Culpepper, William J; Cutter, Gary R; Wallin, Mitchell; Stuve, Olaf

Zhang, Yinan; Salter, Amber; Jin, Shan; Culpepper, William J; Cutter, Gary R; Wallin, Mitchell; Stuve, Olaf.

Afiliação

Zhang Y; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Salter A; Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA.
Jin S; VA Maryland Health Care System, Baltimore, MD, USA.
Culpepper WJ; VA Multiple Sclerosis Center of Excellence-East, Baltimore, MD, USA.
Cutter GR; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
Wallin M; VA Multiple Sclerosis Center of Excellence-East, Baltimore, MD, USA.
Stuve O; Neurology Section, VA North Texas Health Care System, Medical Service Dallas, VA Medical Center, 4500 South Lancaster Rd, Dallas, TX 75216, USA.

Ther Adv Neurol Disord ; 14: 17562864211006499, 2021.

Article em En | MEDLINE | ID: mdl-33868459

Palavras-chave

age; clinical practice; disease-modifying therapies; multiple sclerosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ther Adv Neurol Disord Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google